Ellington Management Group’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-32,300
| Closed | -$1.44M | – | 61 |
|
|
2020
Q1 | $1.44M | Buy |
32,300
+27,000
| +509% | +$1.21M | 0.34% | 46 |
|
|
2019
Q4 | $264K | Buy |
+5,300
| New | +$264K | 0.06% | 329 |
|
|
2018
Q3 | – | Sell |
-17,500
| Closed | -$614K | – | 503 |
|
|
2018
Q2 | $614K | Sell |
17,500
-3,900
| -18% | -$137K | 0.04% | 136 |
|
|
2018
Q1 | $748K | Buy |
+21,400
| New | +$748K | 0.05% | 277 |
|
|
2017
Q4 | – | Sell |
-16,900
| Closed | -$573K | – | 583 |
|
|
2017
Q3 | $573K | Buy |
+16,900
| New | +$573K | 0.1% | 166 |
|
|
2017
Q1 | – | Sell |
-34,200
| Closed | -$934K | – | 676 |
|
|
2016
Q4 | $934K | Buy |
+34,200
| New | +$934K | 0.14% | 67 |
|